Single intravitreal injection of triamcinolone combined with bevacizumab for the treatment of diffuse diabetic macular oedema refractory to grid photocoagulation

Acta Ophthalmologica

Volumn 88, Issue 7, 2010, Pages

  Folgosa, Marco S ^a   Messias, André ^a   Takata, Clécio ^a   Costa, Rogério A ^b   Scott, Ingrid U ^c   Jorge, Rodrigo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hospital de Olhos de Araraquara   (Brazil)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE;

ADULT; AGED; DIABETIC MACULAR EDEMA; FEMALE; HUMAN; LASER COAGULATION; LETTER; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRAOCULAR; MACULAR EDEMA; MALE; MIDDLE AGED; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 78349303072     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01721.x     Document Type: Letter

References (5)

1. Ahmadieh H, Ramezani A, Shoeibi N, et al. (2008): Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 246: 483 - 489. (Pubitemid 351447960)
2. Bakri SJ, &, Kaiser PK, (2005): Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema. Am J Ophthalmol 139: 290 - 294.
3. Bonini-Filho MA, Jorge R, Barbosa JC, Calucci D, Cardillo JA, &, Costa RA, (2005): Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Invest Ophthalmol Vis Sci 46: 3845 - 3849.
4. Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, &, Zhu M, (2006): Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113: 1533 - 1538.
5. Paccola L, Costa RA, Folgosa MS, Barbosa JC, Scott IU, &, Jorge R, (2008): Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). Br J Ophthalmol 92: 76 - 80.